Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia
Public ClinicalTrials.gov record NCT00626392. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized, Double-Blind, Parallel, Acetylsalicylic Acid (ASA) Run-In Study to Evaluate the EFFECTS of Acetylsalicylic Acid on Niaspan®-Induced Flushing in Subjects With Dyslipidemia
Study identification
- NCT ID
- NCT00626392
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Abbott
- Industry
- Enrollment
- 277 participants
Conditions and interventions
Conditions
Interventions
- niacin extended-release (NER) Drug
- aspirin (ASA) Drug
- aspirin placebo (ASA Pbo) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2008
- Primary completion
- Mar 31, 2008
- Completion
- Mar 31, 2008
- Last update posted
- Sep 1, 2009
2008
United States locations
- U.S. sites
- 26
- U.S. states
- 11
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | 35801 | — |
| Not listed | Scottsdale | Arizona | 85251 | — |
| Not listed | Tucson | Arizona | 85710 | — |
| Not listed | Tucson | Arizona | 85712 | — |
| Not listed | Anaheim | California | 92801 | — |
| Not listed | Los Angeles | California | 90057 | — |
| Not listed | Newport Beach | California | 92660 | — |
| Not listed | Stockton | California | 95204 | — |
| Not listed | Vista | California | 90057 | — |
| Not listed | Westlake Village | California | 91361 | — |
| Not listed | Coral Gables | Florida | 33134 | — |
| Not listed | Jacksonville | Florida | 32259 | — |
| Not listed | Miami | Florida | 33186 | — |
| Not listed | Pembroke Pines | Florida | 33027 | — |
| Not listed | West Palm Beach | Florida | 33407 | — |
| Not listed | North Dartmouth | Massachusetts | 02747 | — |
| Not listed | Rochester | New York | 14609 | — |
| Not listed | Charlotte | North Carolina | 28262 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Penndel | Pennsylvania | 19047 | — |
| Not listed | Johnston | Rhode Island | 02919 | — |
| Not listed | Mt. Pleasant | South Carolina | 29464 | — |
| Not listed | Simpsonville | South Carolina | 29681 | — |
| Not listed | Colleyville | Texas | 76034 | — |
| Not listed | Houston | Texas | 77074 | — |
| Not listed | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00626392, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 1, 2009 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00626392 live on ClinicalTrials.gov.